require_once('weilabdb_connection.php'); include_once("analyticstracking.php"); $page="condition"; $condition_id=20190701;//as in webpage file name $database="tbl_condition_month"; $page_title="Condition of the Month - Wei Laboratories, Inc."; $strSQL = "UPDATE tbl_condition_month set viewed =viewed+1 WHERE condition_mo_id=".intVal($condition_id); mysqli_query ($dbConn,$strSQL); ?> include('i.header.php'); ?>
include('i.navbar.php'); ?> $sql="SELECT * from tbl_condition_month"; $sql.=" WHERE condition_mo_id="; $sql.=$condition_id; $result=mysqli_query($dbConn,$sql); if(mysqli_num_rows($result)>0) { $info=mysqli_fetch_array($result); } ?>" class="aMenuButton-page text-center">Download the Entire Protocol of the Condition
}else{?>Login as practitioner to view Wellness Recommendation.
}?>References:
1. “What Is Drug-Induced Lupus?” Lupus Foundation of America, 2019, www.lupus.org/resources/about-drug-induced-lupus.
2. Choi J, Kim ST, Craft J. The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol. 2012;24(6):651–657. doi:10.1016/j.coi.2012.10.004
3. Gottschalk, et al. “Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus.” Frontiers, Frontiers, 14 Oct. 2015, www.frontiersin.org/articles/10.3389/fimmu.2015.00550/full.
4. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol. 2004;22:431–456.
5. Perl A. Pathogenic mechanisms in systemic lupus erythematosus. Autoimmunity. 2009;43(1):1-6.
6. Schwartz N, Chalasani MLS, Li TM, Feng Z, Shipman WD, Lu TT. Lymphatic Function in Autoimmune Diseases. Front Immunol. 2019;10:519. Published 2019 Mar 20. doi:10.3389/fimmu.2019.00519
7. Mortimer PS, Rockson SG. New developments in clinical aspects of lymphatic disease. Journal of Clinical Investigation. 2014;124(3):915-921. doi:10.1172/jci71608
if($logged_in==1){?>" class="aMenuButton-page text-center">Download the Entire Protocol of the Condition
}else{?> }?>" class="aMenuButton-page text-center">Download the Entire Protocol of the Condition
}else{?>Login as practitioner to view Wellness Recommendation.
}?>References:
1. “What Is Drug-Induced Lupus?” Lupus Foundation of America, 2019, www.lupus.org/resources/about-drug-induced-lupus.
2. Choi J, Kim ST, Craft J. The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol. 2012;24(6):651–657. doi:10.1016/j.coi.2012.10.004
3. Gottschalk, et al. “Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus.” Frontiers, Frontiers, 14 Oct. 2015, www.frontiersin.org/articles/10.3389/fimmu.2015.00550/full.
4. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol. 2004;22:431–456.
5. Perl A. Pathogenic mechanisms in systemic lupus erythematosus. Autoimmunity. 2009;43(1):1-6.
6. Schwartz N, Chalasani MLS, Li TM, Feng Z, Shipman WD, Lu TT. Lymphatic Function in Autoimmune Diseases. Front Immunol. 2019;10:519. Published 2019 Mar 20. doi:10.3389/fimmu.2019.00519
7. Mortimer PS, Rockson SG. New developments in clinical aspects of lymphatic disease. Journal of Clinical Investigation. 2014;124(3):915-921. doi:10.1172/jci71608
if($logged_in==1){?>" class="aMenuButton-page text-center">Download the Entire Protocol of the Condition
}else{?> }?>